Clinical Trial Update: Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance TALAzoparib after first-line platinum chemotherapy in advanced malignant pleural or peritoneal mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Peritoneal Mesothelioma
• Malignant Pleural Mesothelioma

Drugs mentioned

• Talazoparib (talazoparib)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Advanced Malignant Pleural or Peritoneal Mesothelioma | Phase 2 | Status: UNKNOWN